DNA-PK interacts with cyclic dinucleotides and inhibits type I interferon responses
Journal of Experimental Medicine · 04.05.2026 · 223 (5)
DOI: 10.1084/jem.20251796 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 24.03.2026. Verfasst von Isabelle K Vila und 29 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, Centre National de la Recherche Scientifique (CNRS) UMR5535 , Mon…. Hauptthemen laut MEDLINE: Interferon Type I, DNA-Activated Protein Kinase, Nucleotides, Cyclic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Institut National du Cancer, Ligue pour la recherche contre le cancer.
Abstract (Originalsprache)
Inflammatory signal termination is critical for the maintenance of homeostasis. Cyclic dinucleotides (CDNs) are second messengers that trigger inflammatory responses through the activation of the stimulator of IFN genes (STING) signaling platform. No broad-acting direct regulator of intracellular CDNs has been identified in mammals to date. We show that the DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a major DNA damage response actor, directly interacts with the intracellular 2′3′-cGAMP CDN through its kinase domain, tempering STING activation. DNA-PKcs also acts on the 3′3′-cGAMP bacterial CDN and pharmacological STING agonists, impacting their bioactivity and ability to mount optimal antiviral responses. STING agonism has been considered as a therapeutic avenue to alleviate immunosuppression in human pathologies. By uncovering DNA-PKcs as a CDN signaling modulator and CDNs as inhibitors of DNA-PKcs kinase activity, we provide critical insights into CDN regulation, with implications for the development of STING-targeting therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, Centre National de la Recherche Scientifique (CNRS) UMR5535 , Montpellier, France.
- Team SOAP, CRCI2NA, Nantes Université, Inserm, CNRS, Université d'Angers Nantes France, Equipe Labellisée Ligue Contre le Cancer , Paris, France.
- Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS UMR9004 , Montpellier, France.
- Institut Pasteur, Virus and Immunity Unit, Université Paris Cité , Paris, France.
- Vaccine Research Institute , Créteil, France.
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
ORCID-Profile: Isabelle K Vila, Yasmine Messaoud-Nacer, Clara Taffoni, Jane Jardine, Roger J Eloiflin, Adeline Augereau, Soumyabrata Guha, Moritz Schussler, Pierre Le Hars, Joe McKellar, Tamara Carvalho, Jeanne Postal, Morgane Chemarin, Joanna Re, Florence Guivel-Benhassine, Raphaëlle Lopez, Kilian Trillet, Jennifer Barrat, Maximin Serbier, Insaf El Mansouri, Charlotte Luchsinger, George P Chrousos, Françoise Porrot, Felipe Diaz-Griffero, Olivier Schwartz, Fabien P Blanchet, Karim Majzoub, Nicolas Bidère, Dimitrios Vlachakis, Nadine Laguette
Förderung
- European Research Council
- Institut National du Cancer
- Ligue pour la recherche contre le cancer
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales
- University of Montpellier
- Fondation ARC
- La Région Languedoc Roussillon
- Fondation de France
Zitieren
APA
Vila, I. K., Messaoud-Nacer, Y., Taffoni, C., Jardine, J., Eloiflin, R. J., Augereau, A., Guha, S., Schussler, M., Le Hars, P., McKellar, J., Carvalho, T., Postal, J., Chemarin, M., Re, J., Guivel-Benhassine, F., Lopez, R., Trillet, K., Barrat, J., Serbier, M., …, & Laguette, N. (2026). DNA-PK interacts with cyclic dinucleotides and inhibits type I interferon responses. Journal of Experimental Medicine, 223(5). https://doi.org/10.1084/jem.20251796
Vancouver
Vila IK, Messaoud-Nacer Y, Taffoni C, Jardine J, Eloiflin RJ, Augereau A, et al. DNA-PK interacts with cyclic dinucleotides and inhibits type I interferon responses. Journal of Experimental Medicine. 2026;223(5). doi:10.1084/jem.20251796
BibTeX
@article{Vila2026,
author = {Vila, Isabelle K and Messaoud-Nacer, Yasmine and Taffoni, Clara and Jardine, Jane and Eloiflin, Roger J and Augereau, Adeline and Guha, Soumyabrata and Schussler, Moritz and Le Hars, Pierre and McKellar, Joe and Carvalho, Tamara and Postal, Jeanne and Chemarin, Morgane and Re, Joanna and Guivel-Benhassine, Florence and Lopez, Raphaëlle and Trillet, Kilian and Barrat, Jennifer and Serbier, Maximin and El Mansouri, Insaf and Luchsinger, Charlotte and Chrousos, George P and Porrot, Françoise and Diaz-Griffero, Felipe and Schwartz, Olivier and Blanchet, Fabien P and Majzoub, Karim and Bidère, Nicolas and Vlachakis, Dimitrios and Laguette, Nadine},
title = {DNA-PK interacts with cyclic dinucleotides and inhibits type I interferon responses},
journal = {Journal of Experimental Medicine},
year = {2026},
volume = {223},
number = {5},
doi = {10.1084/jem.20251796}
}
EUVIMED